Results 61 to 70 of about 373,954 (298)

Relationships between prostaglandin concentrations, a single nucleotide polymorphism in HSD17B12, and reproductive performance in dairy cows

open access: yesJournal of Dairy Science, 2022
: Prostaglandins are involved in multiple processes important for fertility, with previous work in mice highlighting a potential role for the HSD17B12 gene in prostaglandin biosynthesis.
J.L. Juengel   +7 more
doaj  

Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis

open access: yesScientific Reports, 2021
Mesenchymal stem cells (MSCs) administered for therapeutic purposes can be activated by interferon-γ (IFN-γ) secreted from natural killer cells in injured tissues and exert anti-inflammatory effects.
Ryo Kanai   +11 more
doaj   +1 more source

‘Antiflammins’: Two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2 -inhibitory and anti-inflammatory activity [PDF]

open access: yes, 1990
The ‘antiflammin’ nonapeptides P1 and P2 [(1988) Nature 335, 726-730] were synthesized and tested for inhibition of phospholipase A2 and release of prostaglandin E2, and leukotriene C4 in stimulated cells in vitro, and in vivo for anti-inflammatory ...
Marki, F.   +3 more
core   +1 more source

Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway.

open access: yesHuman Reproduction Update, 2015
BACKGROUND Prostaglandin E2 (PGE2) is an essential intrafollicular regulator of ovulation. In contrast with the one-gene, one-protein concept for synthesis of peptide signaling molecules, production and metabolism of bioactive PGE2 requires controlled ...
D. Duffy
semanticscholar   +1 more source

Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation.

open access: yesAmerican Journal of Respiratory Cell and Molecular Biology, 2015
Myofibroblasts, the major effector cells in pathologic fibrosis, derive from the differentiation of fibroblasts driven by mediators such as transforming growth factor-β1 (TGF-β1) and biomechanical signals.
S. Wettlaufer   +4 more
semanticscholar   +1 more source

Bronchoprotective role for endogenous prostaglandin E2

open access: yesThe Lancet, 1995
The possibility that impaired production of bronchoprotective factors contributes to the pathogenesis of asthma cannot be excluded. Prostaglandin E2 (PGE2) could be such a factor. It is a dominant cyclo-oxygenase product of airway epithelium and smooth muscle; it has inhibitory effects on inflammatory cells and pathways involved in bronchoconstriction ...
Pavord, I, Tattersfield, A
openaire   +4 more sources

Sulforaphane inhibits prostaglandin E2 synthesis by suppressing microsomal prostaglandin E synthase 1. [PDF]

open access: yesPLoS ONE, 2012
Sulforaphane (SFN) is a dietary cancer preventive with incompletely characterized mechanism(s) of cancer prevention. Since prostaglandin E2 (PGE2) promotes cancer progression, we hypothesized that SFN may block PGE2 synthesis in cancer cells.
Jiping Zhou   +3 more
doaj   +1 more source

Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?

open access: yesBritish Journal of Pharmacology, 2015
Elevated expression of COX‐2 and increased levels of PGE2 are found in numerous cancers and are associated with tumour development and progression.
G. O’Callaghan, A. Houston
semanticscholar   +1 more source

The Effects of Bee Venom on PLA2, COX-2, iNOS, AA and PG in RAW 264.7 Cells

open access: yesJournal of Pharmacopuncture, 2002
Objectives : The purpose of this study was to investigate the effect of Bee Venom on the lipopolysaccharide-induced expression phospholipase A2, cyclooxygenase-2 and inducible nitrogen oxide synthase, and the generation of arachidonic acid, prostaglandin
Hyun-Chul Jo   +3 more
doaj   +1 more source

Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19? [PDF]

open access: yesarXiv, 2020
The SARS-CoV-2 virus has resulted in a devastating pandemic of COVID-19. Exploring compounds that could offer a breakthrough in treatment is the need of the hour. Re-positioning cheap, freely available and safe drugs is a priority. The paper proposes evidence for the potential use of diethylcarbamazine (DEC) in the treatment of COVID-19.
arxiv  

Home - About - Disclaimer - Privacy